As per a recent study, breakthrough infections boost immune responses against strains of the virus that develops Covid-19.
A breakthrough infection elicits a significant immune reaction toward the Delta strain, according to a research released in the Journal of the American Medical Association (JAMA).
The results, headed by Oregon Health and Science University (OHSU) researchers, show that the immune reaction is probably extremely powerful against additional variations, such as the Omicron version.
According to the Oregon study, those who have been completely vaccinated against COVID-19 and get a breakthrough infection to develop “super immunity,” as the scientists put it. They warn that people who have been immunized should not pursue COVID-19 infection, although mixed immunity may provide some relief to those who have been infected although being vaccinated.
“The increases were substantial, up to a 1,000% increase and sometimes up to 2,000%, so it’s really high immunity. It’s almost ‘super immunity,'” explained professor of molecular microbiology Fikadu Tafesse.
The researchers compared 26 immunized Oregon Health & Science University staff members who already had breakthrough infections to a control group of vaccinated persons who hadn’t had COVID-19.
People that were immunized and subsequently exposed to COVID-19 had significantly higher antibody levels.
Infections with COVID-19 following one shot of the vaccine have been demonstrated to be extremely effective against re-infection in several other experiments.
“What we’re saying is, we know life happens. If you happen to be exposed to the virus, you’ll have this amazing immune response. It mirrors the immunity response we get to the booster.” added Tafesse.
The results will be of importance to some as the extremely infectious omicron strain spreads across the United States, and is probably just what future brings for most immunized persons, according to Gandi.
Omicron seems to be capable to attack persons who have been completely vaccinated, albeit they have only had minor or asymptomatic COVID-19 infections thus far.